Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 15 | 2024 | 909 | 2.370 |
Why?
|
| Pulmonary Sclerosing Hemangioma | 1 | 2018 | 2 | 0.650 |
Why?
|
| Pleural Effusion | 4 | 2024 | 341 | 0.650 |
Why?
|
| Paragonimus westermani | 1 | 2017 | 2 | 0.590 |
Why?
|
| Paragonimiasis | 1 | 2017 | 3 | 0.590 |
Why?
|
| Amphotericin B | 1 | 2017 | 142 | 0.570 |
Why?
|
| Football | 1 | 2023 | 503 | 0.570 |
Why?
|
| Pulmonary Aspergillosis | 1 | 2017 | 47 | 0.560 |
Why?
|
| Telemetry | 2 | 2013 | 199 | 0.460 |
Why?
|
| Pneumonectomy | 5 | 2022 | 1119 | 0.450 |
Why?
|
| Tracheostomy | 3 | 2024 | 426 | 0.450 |
Why?
|
| Thoracic Surgical Procedures | 4 | 2022 | 349 | 0.420 |
Why?
|
| Lung Diseases | 2 | 2023 | 1909 | 0.390 |
Why?
|
| Cough | 5 | 2024 | 594 | 0.370 |
Why?
|
| Surgical Stapling | 2 | 2022 | 98 | 0.350 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2022 | 285 | 0.330 |
Why?
|
| Multiple Pulmonary Nodules | 2 | 2021 | 173 | 0.320 |
Why?
|
| Lung | 4 | 2022 | 10000 | 0.310 |
Why?
|
| Ultrasonography | 3 | 2020 | 5972 | 0.310 |
Why?
|
| Airway Obstruction | 3 | 2024 | 661 | 0.310 |
Why?
|
| Prostheses and Implants | 5 | 2022 | 1271 | 0.310 |
Why?
|
| Pleural Diseases | 2 | 2020 | 137 | 0.300 |
Why?
|
| Stents | 4 | 2024 | 3179 | 0.300 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 2 | 2020 | 250 | 0.290 |
Why?
|
| Pulmonary Medicine | 2 | 2019 | 221 | 0.270 |
Why?
|
| Pulmonary Emphysema | 2 | 2022 | 684 | 0.250 |
Why?
|
| Thoracoscopy | 3 | 2020 | 181 | 0.250 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 13380 | 0.250 |
Why?
|
| Infection Control | 3 | 2020 | 981 | 0.240 |
Why?
|
| Pleurodesis | 1 | 2024 | 46 | 0.230 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2024 | 106 | 0.220 |
Why?
|
| Chest Tubes | 5 | 2024 | 152 | 0.220 |
Why?
|
| Aggression | 1 | 2008 | 750 | 0.210 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 888 | 0.200 |
Why?
|
| Seizures | 2 | 2013 | 2957 | 0.200 |
Why?
|
| Self-Injurious Behavior | 1 | 2008 | 566 | 0.190 |
Why?
|
| Argon Plasma Coagulation | 1 | 2021 | 25 | 0.190 |
Why?
|
| Biopsy | 4 | 2022 | 6766 | 0.190 |
Why?
|
| Videoconferencing | 1 | 2022 | 203 | 0.170 |
Why?
|
| Empyema, Pleural | 1 | 2020 | 61 | 0.170 |
Why?
|
| Quality of Life | 6 | 2024 | 13367 | 0.170 |
Why?
|
| Pneumothorax | 1 | 2023 | 385 | 0.170 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 1329 | 0.170 |
Why?
|
| Pleurisy | 1 | 2019 | 54 | 0.160 |
Why?
|
| Thoracostomy | 1 | 2019 | 74 | 0.160 |
Why?
|
| Pleura | 1 | 2020 | 245 | 0.160 |
Why?
|
| Respiratory Tract Fistula | 1 | 2018 | 25 | 0.160 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2020 | 131 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2008 | 1220 | 0.150 |
Why?
|
| Health Facilities | 1 | 2023 | 580 | 0.150 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2021 | 278 | 0.150 |
Why?
|
| Videotape Recording | 2 | 2020 | 337 | 0.150 |
Why?
|
| Tracheal Stenosis | 1 | 2020 | 228 | 0.150 |
Why?
|
| Electroencephalography | 2 | 2013 | 6225 | 0.140 |
Why?
|
| Deoxyribonucleases | 1 | 2018 | 211 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2020 | 579 | 0.130 |
Why?
|
| Tracheobronchomalacia | 1 | 2018 | 131 | 0.130 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2020 | 1164 | 0.130 |
Why?
|
| Catheters | 1 | 2019 | 427 | 0.130 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2015 | 992 | 0.130 |
Why?
|
| Humans | 43 | 2024 | 761504 | 0.130 |
Why?
|
| Claudins | 1 | 2016 | 117 | 0.120 |
Why?
|
| Critical Pathways | 1 | 2019 | 474 | 0.120 |
Why?
|
| Treatment Outcome | 13 | 2024 | 64680 | 0.110 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 637 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 439 | 0.100 |
Why?
|
| Respiratory System | 1 | 2016 | 563 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2020 | 1033 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2017 | 752 | 0.100 |
Why?
|
| Fibrinolytic Agents | 2 | 2020 | 2084 | 0.100 |
Why?
|
| Pneumonia | 1 | 2023 | 2143 | 0.100 |
Why?
|
| Drainage | 3 | 2024 | 1157 | 0.100 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 2064 | 0.090 |
Why?
|
| Dilatation | 2 | 2024 | 306 | 0.090 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2019 | 942 | 0.090 |
Why?
|
| Aged, 80 and over | 10 | 2024 | 58976 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2024 | 2567 | 0.090 |
Why?
|
| Aged | 18 | 2024 | 169289 | 0.090 |
Why?
|
| Video Recording | 2 | 2013 | 966 | 0.090 |
Why?
|
| Retrospective Studies | 14 | 2024 | 80636 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1813 | 0.090 |
Why?
|
| Decision Making | 2 | 2015 | 3929 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2018 | 1230 | 0.080 |
Why?
|
| Middle Aged | 18 | 2024 | 220895 | 0.080 |
Why?
|
| Female | 21 | 2024 | 392644 | 0.080 |
Why?
|
| Postoperative Complications | 3 | 2020 | 15631 | 0.080 |
Why?
|
| Male | 22 | 2024 | 360804 | 0.080 |
Why?
|
| Aerosols | 2 | 2020 | 635 | 0.070 |
Why?
|
| Cause of Death | 1 | 2018 | 3683 | 0.070 |
Why?
|
| Patient Preference | 1 | 2015 | 924 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2019 | 2321 | 0.070 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2015 | 1175 | 0.070 |
Why?
|
| Respiratory Function Tests | 2 | 2024 | 1682 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3204 | 0.070 |
Why?
|
| Pandemics | 3 | 2020 | 8654 | 0.060 |
Why?
|
| Bronchi | 2 | 2021 | 845 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5336 | 0.060 |
Why?
|
| Prosthesis Implantation | 2 | 2020 | 592 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3201 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5294 | 0.060 |
Why?
|
| Trachea | 2 | 2021 | 1089 | 0.060 |
Why?
|
| Intensive Care Units | 2 | 2018 | 3745 | 0.060 |
Why?
|
| Length of Stay | 3 | 2024 | 6425 | 0.050 |
Why?
|
| Inpatients | 1 | 2015 | 2548 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2273 | 0.050 |
Why?
|
| Adult | 12 | 2024 | 221177 | 0.050 |
Why?
|
| Physicians | 1 | 2020 | 4591 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2723 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12974 | 0.050 |
Why?
|
| Argon | 1 | 2021 | 36 | 0.050 |
Why?
|
| Exhalation | 1 | 2022 | 181 | 0.050 |
Why?
|
| Aspirin | 1 | 2013 | 3133 | 0.050 |
Why?
|
| Hemothorax | 1 | 2020 | 57 | 0.040 |
Why?
|
| Torque | 1 | 2020 | 133 | 0.040 |
Why?
|
| Recurrence | 2 | 2024 | 8465 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2018 | 2927 | 0.040 |
Why?
|
| Electrocoagulation | 1 | 2020 | 152 | 0.040 |
Why?
|
| Infusion Pumps | 1 | 2020 | 163 | 0.040 |
Why?
|
| Time Factors | 4 | 2024 | 39967 | 0.040 |
Why?
|
| Touch Perception | 1 | 2020 | 107 | 0.040 |
Why?
|
| Cryotherapy | 1 | 2020 | 159 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2020 | 5247 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5315 | 0.040 |
Why?
|
| Pulmonary Atelectasis | 1 | 2020 | 143 | 0.040 |
Why?
|
| Manikins | 1 | 2020 | 243 | 0.040 |
Why?
|
| Fusobacterium Infections | 1 | 2019 | 53 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2024 | 54425 | 0.040 |
Why?
|
| Sheep | 1 | 2021 | 1440 | 0.040 |
Why?
|
| Communication | 1 | 2012 | 3873 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 20570 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2021 | 1096 | 0.040 |
Why?
|
| Asthma | 1 | 2016 | 6234 | 0.040 |
Why?
|
| Arylsulfonates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 1702 | 0.030 |
Why?
|
| Animals | 5 | 2021 | 168459 | 0.030 |
Why?
|
| Candidiasis | 1 | 2019 | 365 | 0.030 |
Why?
|
| Antigens, Fungal | 1 | 2016 | 69 | 0.030 |
Why?
|
| Aspergillus | 1 | 2016 | 93 | 0.030 |
Why?
|
| Respiratory Sounds | 1 | 2020 | 702 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2022 | 1264 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 518 | 0.030 |
Why?
|
| Laryngoscopy | 1 | 2020 | 706 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 1157 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2019 | 947 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 617 | 0.030 |
Why?
|
| Clinical Competence | 2 | 2021 | 4792 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2645 | 0.030 |
Why?
|
| Permeability | 1 | 2016 | 723 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12725 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2016 | 392 | 0.030 |
Why?
|
| Models, Animal | 1 | 2020 | 2112 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 2628 | 0.030 |
Why?
|
| Equipment Design | 1 | 2021 | 3510 | 0.030 |
Why?
|
| Resuscitation Orders | 1 | 2015 | 270 | 0.030 |
Why?
|
| Dyspnea | 1 | 2020 | 1347 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2018 | 2048 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 88319 | 0.020 |
Why?
|
| Proxy | 1 | 2012 | 151 | 0.020 |
Why?
|
| Critical Care | 1 | 2024 | 2696 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 10209 | 0.020 |
Why?
|
| Swine | 1 | 2020 | 5915 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2019 | 1408 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2016 | 1502 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2024 | 9318 | 0.020 |
Why?
|
| Young Adult | 2 | 2016 | 59243 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2018 | 2242 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2020 | 2521 | 0.020 |
Why?
|
| Education, Medical | 1 | 2020 | 1725 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8529 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8631 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2020 | 23995 | 0.020 |
Why?
|
| Child | 2 | 2024 | 80153 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6484 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29625 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3429 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3600 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2018 | 9646 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 41487 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9326 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 8002 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10552 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11076 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15266 | 0.010 |
Why?
|
| Cell Line | 1 | 2016 | 15601 | 0.010 |
Why?
|
| Genomics | 1 | 2018 | 5821 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2012 | 3023 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18395 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12795 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14414 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7407 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 18965 | 0.010 |
Why?
|
| Obesity | 1 | 2021 | 12947 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 4016 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22169 | 0.010 |
Why?
|
| United States | 1 | 2021 | 72334 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74206 | 0.010 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_